Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Autoimmune Disorders

  Free Subscription


3 BMC Neurol
2 Brain
7 Diabetes Res Clin Pract
1 Intern Med
1 J Immunol
1 J Neuroimmunol
3 J Neurol
3 J Pediatr Endocrinol Metab
4 J Rheumatol
1 Kidney Int
1 Lancet
1 Mult Scler
1 N Engl J Med
3 Nat Rev Neurol
6 Neurology
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Neurol

  1. JIN Y, Chu H, Dong H, Wang H, et al
    Chronic inflammatory demyelinating polyneuropathy and psoriasis comorbidity with significantly alleviated in symptoms after secukinumab: case report.
    BMC Neurol. 2022;22:400.
    PubMed         Abstract available

  2. POLILLI E, Frattari A, Esposito JE, Angelini G, et al
    SOX-1 antibodies in a patient with Crohn's disease: a case report.
    BMC Neurol. 2022;22:404.
    PubMed         Abstract available

  3. ALI ASHRAFI S, Asadi M, Shanehbandi D, Sadigh Eteghad S, et al
    Association between miRNA-145 and miRNA-155 expression in peripheral blood mononuclear cells of patients with multiple sclerosis: a case-control study.
    BMC Neurol. 2022;22:405.
    PubMed         Abstract available


  4. GARTON T, Gill AJ, Calabresi PA
    Distinct mechanisms of oligodendrocyte injury inform therapeutic interventions in multiple sclerosis.
    Brain. 2022 Nov 3. pii: 6794531. doi: 10.1093.

  5. ROSTGAARD K, Nielsen NM, Melbye M, Frisch M, et al
    Siblings reduce multiple sclerosis risk by preventing delayed primary Epstein-Barr virus infection.
    Brain. 2022 Nov 1. pii: 6783238. doi: 10.1093.
    PubMed         Abstract available

    Diabetes Res Clin Pract

  6. ELEDRISI MS, Alkabbani H, Aboawon M, Ali A, et al
    Clinical characteristics and outcomes of care in patients hospitalized with diabetic ketoacidosis.
    Diabetes Res Clin Pract. 2022;192:110041.
    PubMed         Abstract available

  7. BOZZETTO L, Pacella D, Cavagnuolo L, Capuano M, et al
    Postprandial glucose variability in type 1 diabetes: The individual matters beyond the meal.
    Diabetes Res Clin Pract. 2022;192:110089.
    PubMed         Abstract available

  8. LIMBERT C, Lanzinger S, deBeaufort C, Iotova V, et al
    Diabetes-related antibody-testing is a valuable screening tool for identifying monogenic diabetes - A survey from the worldwide SWEET registry.
    Diabetes Res Clin Pract. 2022;192:110110.
    PubMed         Abstract available

  9. NEJATIAN MM, Lan NSR, Yeap BB, Dwivedi G, et al
    Characteristics and outcomes of patients with type 1 diabetes admitted with acute coronary syndromes.
    Diabetes Res Clin Pract. 2022;192:110093.
    PubMed         Abstract available

  10. TILDEN DR, French B, Shoemaker AH, Corathers S, et al
    Prolonged lapses between pediatric and adult care are associated with rise in HbA1c and inpatient days among patients with type 1 diabetes.
    Diabetes Res Clin Pract. 2022;192:110113.
    PubMed         Abstract available

    A cross-talk between perceptions and reality on insulin therapy among Type-2 diabetes patients in developing countries.
    Diabetes Res Clin Pract. 2022;192:110114.

  12. New global Type 1 Diabetes Index highlights the unmet need of people living with type 1 diabetes.
    Diabetes Res Clin Pract. 2022;192:110123.

    Intern Med

  13. IMAIZUMI C, Ogura T, Inoue Y, Takakura Y, et al
    Reduced Rate of Disease Flares in Japanese Patients with Systemic Lupus Erythematosus: An Altered Balance between the Use of Glucocorticoids and Immunosuppressants in Recent Decades.
    Intern Med. 2022;61:3189-3196.
    PubMed         Abstract available

    J Immunol

  14. MURATA R, Kinoshita S, Matsuda K, Kawaguchi A, et al
    G307S DNAM-1 Mutation Exacerbates Autoimmune Encephalomyelitis via Enhancing CD4(+) T Cell Activation.
    J Immunol. 2022 Nov 2. pii: jimmunol.2200608. doi: 10.4049/jimmunol.2200608.
    PubMed         Abstract available

    J Neuroimmunol

  15. LI X, Chu Y, Ma R, Dou M, et al
    Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2022;373:577995.
    PubMed         Abstract available

    J Neurol

  16. MOCCIA M, Affinito G, Berera G, Marrazzo G, et al
    Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy.
    J Neurol. 2022;269:6504-6511.
    PubMed         Abstract available

  17. PAKEERATHAN T, Havla J, Schwake C, Salmen A, et al
    Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode.
    J Neurol. 2022;269:6366-6376.
    PubMed         Abstract available

  18. OMARY R, Bockisch CJ, De Vere-Tyndall A, Pazahr S, et al
    Lesion follows function: video-oculography compared with MRI to diagnose internuclear ophthalmoplegia in patients with multiple sclerosis.
    J Neurol. 2022 Oct 31. pii: 10.1007/s00415-022-11428.
    PubMed         Abstract available

    J Pediatr Endocrinol Metab

  19. SENBANJO IO, Akinola IJ, Umar UI, Anyabolu CH, et al
    Children and adolescents with type 1 diabetes mellitus in Nigeria: clinical characteristics and compliance with care.
    J Pediatr Endocrinol Metab. 2022;35:1377-1384.
    PubMed         Abstract available

  20. ELHABASHY SA, Abd ElMalak MW, Elrassas HH, Thabet RA, et al
    Disordered eating and behaviors among young Egyptians with type 1 diabetes: risk factors and comorbidities.
    J Pediatr Endocrinol Metab. 2022;35:1385-1393.
    PubMed         Abstract available

  21. SOBU E, Yildiz Z
    Does cystatin C have an immunomodulatory role in Hashimoto's thyroiditis?
    J Pediatr Endocrinol Metab. 2022 Nov 4. pii: jpem-2022-0386.
    PubMed         Abstract available

    J Rheumatol

  22. YOSHINARI M, Hattanda F, Nishibata Y, Masuda S, et al
    A Novel Antineutrophil Extracellular Trap Antibody Targeting Myosin Light Chain 6 in Microscopic Polyangiitis.
    J Rheumatol. 2022;49:1286-1288.

  23. JOHNSON SR, Martinez JPD, Whittall-Garcia L, Urowitz MB, et al
    Evaluating the threshold score for classification of systemic lupus erythematosus using the EULAR/ACR criteria.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220100. doi: 10.3899/jrheum.220100.
    PubMed         Abstract available

  24. ZHUO N, Wang G, Li J, Liu Y, et al
    Systemic Lupus Erythematosus Flares During Dialysis in Patients With Endstage Renal Disease.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220947. doi: 10.3899/jrheum.220947.
    PubMed         Abstract available

  25. SEO P, Winthrop K, Sawalha AH, Choi S, et al
    Physicians' perspective on vaccination in patients with autoimmune inflammatory rheumatic diseases: an international survey.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220135. doi: 10.3899/jrheum.220135.
    PubMed         Abstract available

    Kidney Int

  26. SHIM JS, Kim EJ, Lee LE, Kim JY, et al
    The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosus.
    Kidney Int. 2022 Nov 1. pii: S0085-2538(22)00913.
    PubMed         Abstract available


  27. WIECH T, Reinhard L, Wulf S, Giuffrida AE, et al
    Bacterial infection possibly causing autoimmunity: Tropheryma whipplei and membranous nephropathy.
    Lancet. 2022 Oct 31. pii: S0140-6736(22)02039.

    Mult Scler

  28. VUKUSIC S, Carra-Dalliere C, Ciron J, Maillart E, et al
    Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society.
    Mult Scler. 2022 Nov 1:13524585221129472. doi: 10.1177/13524585221129472.
    PubMed         Abstract available

    N Engl J Med

    Pharmaceutical Marketing Revisited - United States v. Biogen Idec.
    N Engl J Med. 2022;387:1631-1633.

    Nat Rev Neurol

    FDA-approved drug promotes remyelination.
    Nat Rev Neurol. 2022;18:637.

    Brain volume is associated with cognition in MS.
    Nat Rev Neurol. 2022;18:637.

  32. KIANI L
    No seasonality in multiple sclerosis risk near the Equator.
    Nat Rev Neurol. 2022 Nov 1. pii: 10.1038/s41582-022-00743.


  33. LEWIS A, Galetta S
    Editors' Note: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Neurology. 2022;99:818.

  34. BEBO BF
    Author Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Neurology. 2022;99:819.

    Reader Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Neurology. 2022;99:818-819.

  36. LI L, Avina-Zubieta JA, Bernstein CN, Kaplan GG, et al
    Risk of Multiple Sclerosis Among Users of Antitumor Necrosis Factor Alpha in Four Canadian Provinces: A Population-Based Study.
    Neurology. 2022 Oct 28. pii: WNL.0000000000201472.
    PubMed         Abstract available

  37. Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
    Neurology. 2022 Oct 28. pii: WNL.0000000000201391.

    TNF Alfa Blockers and the Risk of Multiple Sclerosis.
    Neurology. 2022 Oct 28. pii: WNL.0000000000201629.

    PLoS One

  39. GRANLUND L, Hedin A, Korsgren O, Skog O, et al
    Altered microvasculature in pancreatic islets from subjects with type 1 diabetes.
    PLoS One. 2022;17:e0276942.
    PubMed         Abstract available

  40. AMATYA M, Pant AD
    Clinical and histopathological study of renal biopsy in Nepalese children: A single center experience.
    PLoS One. 2022;17:e0276172.
    PubMed         Abstract available

  41. DAVID BL, Ivan GJ, Emilio PE, Daniela MJ, et al
    Low serum uromodulin levels and their association with lupus flares.
    PLoS One. 2022;17:e0276481.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.